MediGene AG

MediGene AG

MediGene AG

Overview
Date Founded

1996

Headquarters

Lochhamer Straße 11,Planegg,Martinsried, Bayern (Bavaria) 82152

Type of Company

Public

Employees (Worldwide)

142

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals

Company Description

MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.

Contact Data
Trying to get in touch with decision makers at MediGene AG? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive & Scientific Officer

Chief Financial Officer & Chief Business Development Officer

Chief Medical Officer & Chief Development Officer

Vice President, Head of Business Development

Director Investor Relations

Senior Manager-Public Relations

Deputy Chairman of the Supervisory Board

Media Relations Contact

Board of Directors

Founder at Wellington Partners GmbH

Paths to MediGene AG
Potential Connections via
Relationship Science
You
MediGene AG
Recent Transactions
Details Hidden

SynCore Biotechnology Co., Ltd. purchases Medigene AG /EndoTAG Technology Platform from MediGene AG

Details Hidden

MediGene AG purchases Medigene Immunotherapies GmbH from BioM AG Munich BioTech Development, Ascenion GmbH

Details Hidden

MediGene AG purchases Catherex, Inc.

Transaction Advisors
Global Coordinator

Advised onMediGene AG issued EUR Ordinary Shares

Underwriter

Advised onMediGene AG issued EUR Ordinary Shares

Investment Advisor

Advised onMediGene AG purchases NeuroVir Therapeutic, Inc. resulting in a new company MediGene, Inc.

Legal Advisor

Advised onMediGene AG purchases Medigene Immunotherapies GmbH from BioM AG Munich BioTech Development, Ascenion GmbH

Legal Advisor

Advised onMediGene AG purchases Medigene Immunotherapies GmbH from BioM AG Munich BioTech Development, Ascenion GmbH

Legal Advisor

Advised onMediGene AG purchases Medigene Immunotherapies GmbH from BioM AG Munich BioTech Development, Ascenion GmbH

Clients

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland.

Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, therapeutic drugs, medicated cosmetics, nutriment, health care foods, and cleaning liquid. Its activities include the manufacturing and selling of healthy products and raw materials. The company's operations are carried out in Taiwan, China, Australia and North America. Sinphar Pharmaceutical was founded on July 2, 1977 and is headquartered in I-lan, Taiwan.

Key Stats and Financials As of 2019
Market Capitalization
$134M
Total Enterprise Value
$55.6M
Earnings Per Share
$-0.93
EBITDAMargin
-170.39%
Enterprise Value / Sales
4.62x
TEVNet Income
-2.44x
Debt TEV
0.1x
Three Year Compounded Annual Growth Rate Of Revenue
36.85%
Revenue
$12M
Net Profit
$-22.8M
EBITDA
$-20.5M
Total Debt
$5.77M
Total Equity
$93.5M
Suppliers
BioNTech SE Hospitals & Patient Services | Mainz, Germany

BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Leids Universitair Medisch Centrum Hospitals & Patient Services | Leiden, Netherlands

Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by MediGene AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of MediGene AG's profile does not indicate a business or promotional relationship of any kind between RelSci and MediGene AG.